Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome
- PMID: 19804614
- PMCID: PMC2787303
- DOI: 10.1186/ar2805
Use of methotrexate therapy is not associated with decreased prevalence of metabolic syndrome
Comment on
-
Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.Arthritis Res Ther. 2009;11(4):R110. doi: 10.1186/ar2765. Epub 2009 Jul 16. Arthritis Res Ther. 2009. PMID: 19607680 Free PMC article.
References
-
- Toms TE, Panoulas VF, Douglas KMJ, Kitas GD. Methotrexate therapy associates with a reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60: more than just an anti-inflammatory effect? A cross-sectional study. Arthritis Res Ther. 2009;11:R110. doi: 10.1186/ar2765. - DOI - PMC - PubMed
-
- Raterman HG, van Eijk IC, Voskuyl AE, Peters MJ, Dijkmans BA, van Halm VP, Simsek S, Lems WF, Nurmohamed MT. The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study. Ann Rheum Dis. 2008. in press . - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
